FK866 (APO866): Precision NAMPT Inhibition in AML Research
2026-07-06
FK866 (APO866) delivers highly specific and potent inhibition of NAMPT, enabling selective cytotoxicity in acute myeloid leukemia (AML) research models while safeguarding healthy progenitors. This article guides researchers through optimized protocols, advanced applications, and troubleshooting strategies for leveraging FK866 in hematologic cancer and innate immunity studies.
Translocon Remodeling During ER Protein Synthesis: Global In
2026-07-05
This study provides a comprehensive, transcriptome-wide analysis of how translocon complexes at the endoplasmic reticulum (ER) dynamically remodel in response to nascent substrate properties during protein synthesis. By leveraging selective ribosome profiling, the researchers delineate the molecular logic underpinning the recruitment and coordination of accessory factors essential for secretory and multipass membrane protein biogenesis.
Molnupiravir Suppresses Bourbon Virus in Murine Models: New
2026-07-04
This study demonstrates that molnupiravir, a broad-spectrum antiviral, significantly inhibits Bourbon virus (BRBV) replication and disease pathology in mice. The findings establish a strong preclinical rationale for evaluating nucleoside analogues in emerging tick-borne viral infections lacking approved therapies.
ICAA Targets RIP3 to Alleviate Angiotensin II Cardiac Hypert
2026-07-03
The reference study demonstrates that isochlorogenic acid A (ICAA) mitigates angiotensin II-induced cardiac hypertrophy by directly inhibiting RIP3 phosphorylation and the downstream CaMKII pathway. These findings introduce a new regulatory axis in cardiac hypertrophy and suggest novel intervention points for cardiovascular disease research.
Integrating TLR1/2 Agonism and Neuro-Immune Reflexes in Infl
2026-07-03
Explore how Pam3CSK4-mediated TLR1/2 activation and TRPV1+ nerve stimulation converge to unlock new strategies for immune modulation. This thought-leadership article delivers mechanistic insight, translational context, and actionable protocol guidance for researchers seeking precision in inflammation models.
AEBSF.HCl in Lysosomal and Amyloid Research: Protocols & Adv
2026-07-02
AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) empowers researchers to dissect complex protease-driven pathways in necroptosis and amyloid-beta modulation with reproducible precision. This guide delivers actionable workflows, troubleshooting wisdom, and a synthesis of cutting-edge findings, bridging fundamental cell death mechanisms and neurodegenerative disease research.
AM 281: Advanced CB1 Cannabinoid Receptor Antagonist Workflo
2026-07-02
AM 281 stands out as a highly selective CB1 cannabinoid receptor antagonist, enabling precise dissection of endocannabinoid signaling in neuropharmacology. Explore protocol optimizations, troubleshooting strategies, and innovative use-cases in memory impairment and traumatic brain injury research.
Optimizing Apoptosis Assays with ABT-263 (Navitoclax): Lab I
2026-07-01
This article addresses common laboratory challenges in apoptosis and cytotoxicity research by demonstrating how ABT-263 (Navitoclax), SKU A3007, delivers reproducible, data-driven solutions. Grounded in recent literature and practical workflows, it compares vendor reliability, protocol optimization, and quantitative assay outcomes—empowering life science researchers to make informed, evidence-based choices.
QRICH1 Drives HBV-Linked HMGB1 Secretion and Hepatic Fibrosi
2026-07-01
The reference study identifies QRICH1 as a pivotal mediator of endoplasmic reticulum (ER) stress in the context of HBV infection, promoting HMGB1 translocation and secretion in hepatocytes. These mechanistic insights deepen our understanding of how ER stress effectors contribute to HBV-induced hepatic fibrosis and highlight new molecular targets for intervention.
Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Robust
2026-06-30
Sulfo-Cy3 NHS Ester delivers unmatched hydrophilicity and water solubility for efficient, quenched-minimized fluorescent labeling of proteins and peptides. Its performance advantages empower advanced workflows in cell biology, vascular remodeling, and quantum dot conjugation, especially for challenging low-solubility biomolecules.
NU6300 Inhibits Gasdermin D via Cysteine-191 Targeting in Py
2026-06-30
Jiang et al. identify NU6300 as a covalent inhibitor that specifically reacts with cysteine-191 of gasdermin D (GSDMD), blocking its cleavage and palmitoylation to inhibit pyroptosis. This work advances the understanding of pyroptosis modulation and highlights new avenues for targeting inflammatory diseases.
Remdesivir (GS-5734): Applied Workflows for Antiviral Resear
2026-06-29
Remdesivir (GS-5734) stands out as a gold-standard tool for investigating RNA virus inhibition, with well-quantified efficacy and broad-spectrum versatility. This guide delivers actionable protocols, troubleshooting insights, and comparative applications for robust coronavirus and Ebola virus research.
ABT-888 (Veliparib): Advanced Strategies for DNA Repair Inhi
2026-06-29
Explore how ABT-888 (Veliparib) enables innovative cancer research through selective DNA repair inhibition. This article reveals new assay strategies and practical insights not found in existing guides.
Sitagliptin Phosphate Monohydrate: Applied DPP-4 Inhibitor W
2026-06-28
Sitagliptin phosphate monohydrate enables precise modeling of incretin hormone modulation and glucose homeostasis, with robust workflows for cellular and animal metabolic research. This guide details reproducible protocols, troubleshooting strategies, and the latest experimental insights to help researchers maximize the utility of this potent DPP-4 inhibitor.
IGF2BP1 Drives Macrophage Glycolysis and Fibrosis via THBS1
2026-06-27
This study reveals that the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA in macrophages, supporting glycolytic metabolism and M2 polarization. These findings clarify a regulatory axis (IGF2BP1/THBS1/TLR4) that links epigenetic RNA modification to macrophage-driven fibrotic pathology, offering fresh mechanistic insight and therapeutic targets.
461 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page